Evidence map›Paper›PMID 12805223›Full record

ArticleThe EMBO journal2003

Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia.

Eckhard Flechsig, Ivan Hegyi, Rainer Leimeroth, Armando Zuniga, Daniela Rossi, Antonio Cozzio, Petra Schwarz, Thomas Rülicke, Jürgen Götz, Adriano Aguzzi and 1 more

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Prion disease: a tale of folds and strains.Brain pathology (Zurich, Switzerland) · 2013
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. N-terminally deleted forms of the prion protein activate both Bax-dependent and Bax-independent neurotoxic pathways.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2007
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 3 countries.

Eckhard FlechsigInstitut für Molekularbiologie, Universität Zürich, CH-8057 Zürich, Switzerland.
Ivan Hegyi
Rainer Leimeroth
Armando Zuniga
Daniela Rossi
Antonio Cozzio
Petra Schwarz
Thomas Rülicke
Jürgen Götz
Adriano Aguzzi
Charles Weissmann
University College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PrP knockout mice with disruption of only the PrP-encoding region (Zürich I-type) remain healthy, whereas mice with deletions extending upstream of the PrP-encoding exon (Nagasaki-type) suffer Purkinje cell loss and ataxia, associated with ectopic expression of Doppel in brain, particularly in Purkinje cells. The phenotype is abrogated by co-expression of full-length PrP. Doppel is 25% similar to PrP, has the same globular fold, but lacks the flexible N-terminal tail. We now show that in Zürich I-type PrP-null mice, expression of N-terminally truncated PrP targeted to Purkinje cells also leads to Purkinje cell loss and ataxia, which are reversed by PrP. Doppel and truncated PrP probably cause Purkinje cell degeneration by the same mechanism.

Indexed as

Cell DeathAllelesAnimalsAtaxiaBrainGPI-Linked ProteinsImmunohistochemistryMiceMice, TransgenicPrionsPromoter Regions, GeneticPurkinje CellsTime FactorsGPI-Linked ProteinsPrionsPrnd protein, mouse

Identifiers

PMID12805223
PMCPMC162137
OpenAlexW2111784654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.